Stammdaten
Unternehmen
| Name | Vir Biotechnology, Inc. |
|---|---|
| Ticker | VIR |
| CIK | 0001706431 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Vir Biotechnology, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:23:10.256116 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | SATO VICKI L | Director | Open Market Sale | -200 | 9.98 | -1,996.00 | -1,5% | |
| 2026-03-02 | SATO VICKI L | Director | Open Market Sale | -21,800 | 9.50 | -207,185.02 | -152,9% | |
| 2026-02-24 | O'Byrne Jason | Officer, EVP & Chief Financial Officer | Open Market Sale | -1,634 | 9.53 | -15,576.27 | -11,5% | |
| 2026-02-24 | De Backer Marianne | Director, Officer, Chief Executive Officer | Open Market Sale | -14,762 | 9.53 | -140,720.24 | -103,9% | |
| 2026-02-24 | SATO VICKI L | Director | Open Market Sale | -42,177 | 9.75 | -411,314.32 | -303,6% | |
| 2026-02-24 | SATO VICKI L | Director | Open Market Sale | -200 | 10.26 | -2,052.00 | -1,5% | |
| 2026-02-23 | O'Byrne Jason | Officer, EVP & Chief Financial Officer | Open Market Sale | -2,089 | 7.45 | -15,568.90 | -11,5% | |
| 2026-02-23 | De Backer Marianne | Director, Officer, Chief Executive Officer | Open Market Sale | -19,039 | 7.45 | -141,893.86 | -104,7% | |
| 2026-02-02 | SATO VICKI L | Director | Open Market Sale | -22,000 | 7.71 | -169,670.60 | -125,2% | |
| 2026-01-02 | SATO VICKI L | Director | Open Market Sale | -22,000 | 5.93 | -130,383.00 | -96,2% | |
| 2025-12-01 | SATO VICKI L | Director | Open Market Sale | -22,000 | 6.00 | -132,070.40 | -97,5% | |
| 2025-11-17 | O'Byrne Jason | Officer, EVP & Chief Financial Officer | Open Market Sale | -6,799 | 5.56 | -37,782.04 | -27,9% | |
| 2025-11-03 | SATO VICKI L | Director | Open Market Sale | -22,000 | 5.64 | -124,047.00 | -91,6% | |
| 2025-10-01 | SATO VICKI L | Director | Open Market Sale | -22,000 | 5.84 | -128,396.40 | -94,8% | |
| 2025-09-02 | SATO VICKI L | Director | Open Market Sale | -22,000 | 4.99 | -109,810.80 | -81,0% | |
| 2025-09-02 | SATO VICKI L | Director | Open Market Sale | -22,000 | 4.99 | -109,810.80 | -81,0% | |
| 2025-08-01 | SATO VICKI L | Director | Open Market Sale | -22,000 | 4.99 | -109,698.60 | -81,0% | |
| 2025-07-01 | SATO VICKI L | Director | Open Market Sale | -22,000 | 5.10 | -112,206.60 | -82,8% | |
| 2025-04-03 | De Backer Marianne | Director, Officer, Chief Executive Officer | Open Market Sale | -79,712 | 5.95 | -474,238.57 | -350,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.